CHRS vs BIIB: Which Stock is Better?
Side-by-side comparison of Coherus BioSciences Inc and Biogen Inc in 2026
CHRS
Coherus BioSciences Inc
—
BIIB
Biogen Inc
$205.70
Key Metrics Comparison
| Metric | CHRS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $223.66M | $29.33B | BIIB |
| P/E Ratio | N/A | 21.39 | BIIB |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CHRS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHRS or BIIB a better investment?
Comparing CHRS and BIIB: Coherus BioSciences Inc has a market cap of $223.66M while Biogen Inc has $29.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHRS and BIIB?
CHRS (Coherus BioSciences Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHRS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHRS or BIIB?
Both CHRS and BIIB show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CHRS or BIIB?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CHRS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $29.33B compared to $223.66M for CHRS.
Should I buy CHRS or BIIB in 2026?
Both CHRS and BIIB have investment merit. CHRS trades at $N/A while BIIB trades at $205.70. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHRS and BIIB stock?
Key differences: Market Cap ($223.66M vs $29.33B), P/E Ratio (N/A vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CHRS or BIIB in 2026?
The choice between CHRS and BIIB depends on your investment goals. BIIB shows higher revenue growth (0.0%). BIIB has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CHRS and BIIB?
CHRS (Coherus BioSciences Inc) has a market cap of $223.66M, while BIIB (Biogen Inc) has a market cap of $29.33B. BIIB is the larger company by market value.